Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

NCT05949801 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Systolic Heart Failure

Interventions

DRUG: Neucardin
DRUG: Placebo

Sponsor

Zensun Sci. & Tech. Co., Ltd.